Modifications of Low-Molecular Weight Heparin Use in a French University Hospital after Implementation of New Guidelines

Author： Leclerc-Foucras Sophie Bagheri Haleh Samii Kamran Montastruc Jean-Louis Lapeyre-Mestre Maryse

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.30, Iss.5, 2007-01, pp. : 409-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reviparin sodium – a new low molecular weight heparin

By Breddin Hans Klaus

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 173-182

Informa Healthcare

Access to resources Recommend Favorite

Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Wang Xu-Kai Zhang Ye Yang Cheng-Ming Wang Yan Liu Guang-Yao

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 341-349

Adis International

Access to resources Recommend Favorite

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien Gajdziok Jan Rabišková Miloslava Bonneaux François Lecompte Thomas Sapin Anne Maincent Philippe

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low molecular weight heparin in acute stroke

By Bath P.M.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 8, 1998-08 ,pp. : 1323-1330

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin in Acute Coronary Syndromes

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite